Clinical Trial Update: An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation [Phase 3]

View source ↗

Summary

Open-label, long-term safety study of linaclotide in chronic constipation and irritable bowel syndrome with constipation completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Irritable Bowel Syndrome With Constipation, Chronic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2018-02-19